The interplay of established cell cycle events in the pathogenesis in MCL. Loss of cell cycle–dependent kinase inhibitor influence (i.e., p16, p21 or p27) synergizes with the driving force of cyclin D1 overexpression. P53 is more commonly mutated in cases of blastic mantle cell lymphoma